Neuronetics

UnverifiedFacts from public sources. Is this your company? Claim your page.

Health tech & servicesMalvern, PAFounded 2003Nasdaq: STIM

Overview

Neuronetics makes the NeuroStar Advanced Therapy System, an office-based transcranial magnetic stimulation (TMS) treatment cleared by the FDA for adults with major depressive disorder and other indications, and sells systems and recurring treatment sessions mainly to psychiatrists. Since acquiring Greenbrook TMS in December 2024 it also operates Greenbrook Treatment Centers, a network of 93 U.S. outpatient centers offering TMS and SPRAVATO. It reports two segments, medical device and clinic services, and the sales roles differ: NeuroStar reps sell to practices, while Greenbrook account managers build provider referrals to the centers.

Hiring snapshot

Open roles

Newest first, from Neuronetics’s careers page.

See all 12 roles →

Divisions

Division information is pending company verification.Once Neuronetics claims its page, you will see each division, who it calls on and how it pays.

Claim your page

More from Neuronetics

These sections fill in when Neuronetics claims and verifies its page.

Life at NeuroneticsPhotos, stories and culture. Not added yet.
BenefitsNot added yet.
Is this your company? Claim your page →